Molecular quantification of tissue disease burden is a new biomarker and independent predictor of survival in mastocytosis.
Greiner G, Gurbisz M, Ratzinger F, Witzeneder N, Class SV, Eisenwort G, Simonitsch-Klupp I, Esterbauer H, Mayerhofer M, Müllauer L, Sperr WR, Valent P, Hoermann G.
Greiner G, et al. Among authors: mullauer l.
Haematologica. 2020 Jan 31;105(2):366-374. doi: 10.3324/haematol.2019.217950. Print 2020.
Haematologica. 2020.
PMID: 31018976
Free PMC article.